BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Elevation Oncology, Inc. (ELEV)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Elevation Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:28 pm
Purchase		 2024-09-30 13G Elevation Oncology, Inc.
ELEV		 BIOTECHNOLOGY VALUE FUND L P 6,230,845
9.990%		 1,779,960increase
(+39.99%)		 Filing
2024-02-14
10:01 am
Purchase		 2023-12-31 13G Elevation Oncology, Inc.
ELEV		 BIOTECHNOLOGY VALUE FUND L P 4,450,885
9.990%		 2,138,685increase
(+92.50%)		 Filing
2023-02-13
6:05 pm
Purchase		 2022-12-31 13G Elevation Oncology, Inc.
ELEV		 BIOTECHNOLOGY VALUE FUND L P 2,312,200
9.900%		 700,502increase
(+43.46%)		 Filing
2022-02-14
1:46 pm
Purchase		 2021-12-31 13G Elevation Oncology, Inc.
ELEV		 BIOTECHNOLOGY VALUE FUND L P 1,611,698
6.900%		 1,611,698increase
(New Position)		 Filing